World Stunned as ‘Frozen in Time' 1994 Embryo Gives Birth to Baby in 2025, Sparking Fierce Debate on Ethics and the Future of Parenthood
, setting a new world record in reproductive medicine. ❄️ The embryo was originally created in 1994 through in vitro fertilization (IVF) and was adopted by Lindsey and Tim Pierce from Ohio.
and was adopted by Lindsey and Tim Pierce from Ohio. 🏥 The birth took place at Rejoice Fertility in Tennessee, highlighting advancements in IVF technology and embryo preservation.
in Tennessee, highlighting advancements in IVF technology and embryo preservation. 👨👩👦 This event underscores the potential of embryo adoption programs, offering new opportunities for families struggling with infertility.
In a groundbreaking event that has captured the attention of the medical community and the public alike, a baby boy has been born in the United States from an embryo that was frozen for over three decades. This remarkable occurrence sets a new record for the longest-stored embryo to result in a successful live birth. Thaddeus Daniel Pierce, born on July 26, 2025, to Ohio parents Lindsey and Tim Pierce, is being heralded as the world's 'oldest baby.' The embryo, originally created in 1994, was cryopreserved for 31 years, marking a significant milestone in the field of reproductive medicine. Embryo Frozen for 31 Years
The journey of this particular embryo began in the early 1990s when Linda Archerd and her husband pursued in vitro fertilization (IVF) to start their family. In 1994, the process resulted in four embryos. One of these embryos was transferred successfully, leading to the birth of their daughter, who is now 30 years old. The remaining embryos were cryogenically preserved and stored for future use.
Over the years, Linda faced increasing annual storage fees, which eventually reached a thousand dollars. As the financial burden grew, she discovered the concept of embryo adoption through the Nightlight Christian Adoptions' 'Snowflakes' program. This innovative program allows donated embryos to be adopted by new families, giving them a chance at life.
'From Trash to Treasure' as MIT's New 3D Printer Turns Rotting Food Scraps Into Household Items and Sparks Fierce Debate Over Waste, Sustainability, and Safety
Linda was matched with the Pierces, a couple who shared her values and were eager to expand their family. Although Lindsey and Tim Pierce were not attempting to set any records, their primary goal was to have a baby. Despite a challenging birth, both Lindsey and Thaddeus are now doing well. Lindsey expressed her awe and gratitude, stating, 'We are in awe that we have this precious baby.' Major Advancement in IVF
The successful birth of Thaddeus highlights major advancements in IVF technology and practices. Rejoice Fertility, the Tennessee clinic responsible for the embryo transfer, is dedicated to giving every embryo a chance at life, regardless of its age. This commitment is particularly significant as some agencies tend to avoid working with older embryos due to concerns about their viability after thawing.
'Men Can Smell When You're Fertile' as Study Finds Women's Ovulation Scent Triggers Happiness and Sparks Explosive Debate Over Biology and Consent
Previously, the record for the longest-frozen embryo to result in a live birth was held by twins born in 2022 from embryos frozen in 1992. The birth of Thaddeus shatters this record and emphasizes the progress made in reproductive medicine since the first successful IVF birth in 1978.
The advancements in assisted reproductive technology have been monumental, providing hope and possibilities for families worldwide.
https://www.sustainability-times.com/research/we-just-saw-another-world-as-james-webb-captures-first-image-of-nearby-alien-planet-and-triggers-wild-debate-over-life-beyond-earth-and-what-comes-next/ Understanding In Vitro Fertilization
In vitro fertilization is a fertility treatment that involves several steps. Initially, eggs are retrieved from a woman's ovaries and fertilized by sperm in a controlled laboratory setting. Once fertilized, the resulting embryos can either be transferred into the woman's womb to achieve pregnancy or cryopreserved for future use. This process offers couples the flexibility to attempt pregnancy at a later time, adapting to their personal and financial circumstances.
The number of IVF births has been on the rise globally, reflecting the growing acceptance and success of this technology. Couples facing infertility challenges now have a viable option to start or expand their families. The birth of Thaddeus Pierce underscores the potential of IVF to overcome biological and temporal barriers, making it a beacon of hope for many. The Impact of Embryo Adoption
Embryo adoption is an emerging option for families unable to conceive naturally. It involves adopting embryos that have been donated by other families after successful IVF treatments. Programs like Nightlight Christian Adoptions' 'Snowflakes' have facilitated this process, allowing embryos to find new homes and families.
For the Archerds and the Pierces, embryo adoption has been a life-changing experience. It underscores the importance of sharing resources and opportunities, enabling families to experience the joy of parenthood. The success of this practice could inspire more families to consider donating unused embryos, potentially transforming countless lives.
The story of Thaddeus Daniel Pierce is not just a medical marvel but a testament to human innovation and compassion. As reproductive technologies continue to evolve, they pose ethical, medical, and emotional questions that society must address. How will these advancements shape our understanding of family and parenthood in the decades to come?
This article is based on verified sources and supported by editorial technologies.
Did you like it? 4.5/5 (24)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
France 24
a day ago
- France 24
Ozempic maker Novo Nordisk posts strong results but competition weighs
The group reported a net profit of 26.5 billion kroner ($4.1 billion), a 32 percent increase from the same period last year, while sales increased by 18 percent to 76 billion kroner. The drug maker lowered its annual earnings outlook last week, causing its share price to continue its nearly year-long slide. The company had already cut its forecast in May and announced the departure of its chief executive Lars Fruergaard Jorgensen. "In May we mostly thought the bottom was reached," Mikael Bak, director of the Danish shareholders' association, told AFP. Bak said "every is a bit surprised" that the situation has deteriorated. "So now we don't want to see more disappointments, there are reasons to believe the business is healthy, the institution and the products good," he said. Novo Nordisk announced last week that it was promoting Maziar Mike Doustdar, its vice president for international operations, to succeed Jorgensen. The popularity of Novo Nordisk's weight-loss treatments had once made it a darling of investors, boosting its share price and at one point making it Europe's most valuable company. But it now faces growing competition from rival treatments made by US group Eli Lilly in United States. A rule by the US Food and Drug Administration allowing pharmacies to create so-called "compound" copycat versions of the drug, after high demand led to shortages, has also dented Novo Nordisk's earnings.
France 24
a day ago
- France 24
RFK Jr. to cancel $500 million in funding for vaccine development
The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed to fight respiratory viruses like Covid-19 and the flu. Robert F. Kennedy Jr. announced in a statement Tuesday that 22 projects, totaling $500 million, to develop vaccines using mRNA technology will be halted. Kennedy's decision to terminate the projects is the latest in a string of decisions that have put the longtime vaccine critic's doubts about shots into full effect at the nation's health department. Kennedy has pulled back recommendations around the Covid-19 shots, fired the panel that makes vaccine recommendations, and refused to offer a vigorous endorsement of vaccinations as a measles outbreak worsened. The health secretary criticised mRNA vaccines in a video on his social media accounts, explaining the decision to cancel projects being led by the nation's leading pharmaceutical companies, including Pfizer and Moderna, that offer protection against viruses like the flu, Covid-19 and H5N1. 'To replace the troubled mRNA programs, we're prioritizing the development of safer, broader vaccine strategies, like whole-virus vaccines and novel platforms that don't collapse when viruses mutate," Kennedy said in the video. Infectious disease experts say the mRNA technology used in vaccines is safe, and they credit its development during the first Trump administration with slowing the 2020 coronavirus pandemic. Future pandemics, they warned, will be harder to stop without the help of mRNA. 'I don't think I've seen a more dangerous decision in public health in my 50 years in the business,' said Mike Osterholm, a University of Minnesota expert on infectious diseases and pandemic preparations. He noted mRNA technology offers potential advantages of rapid production, crucial in the event of a new pandemic that requires a new vaccine. The shelving of the mRNA projects is short-sighted as concerns about a bird flu pandemic continue to loom, said Dr. Paul Offit, a vaccine expert at Children's Hospital of Philadelphia. 'It's certainly saved millions of lives,' Offit said of the existing mRNA vaccines. Scientists are using mRNA for more than infectious disease vaccines, with researchers around the world exploring its use for cancer immunotherapies. At the White House earlier this year, billionaire tech entrepreneur Larry Ellison praised mRNA for its potential to treat cancer. Traditionally, vaccines have required growing pieces of viruses, often in chicken eggs or giant vats of cells, then purifying that material. The mRNA approach starts with a snippet of genetic code that carries instructions for making proteins. Scientists pick the protein to target, inject that blueprint and the body makes just enough to trigger immune protection – producing its own vaccine dose. In a statement Tuesday, HHS said 'other uses of mRNA technology within the department are not impacted by this announcement". The mRNA technology is used in approved Covid-19 and RSV shots, but has not yet been approved for a flu shot. Moderna, which was studying a combination Covid-19 and flu mRNA shot, had said it believed mRNA could speed up production of flu shots compared with traditional vaccines. The abandoned mRNA projects signal a 'shift in vaccine development priorities", the health department said in its statement, adding that it will start 'investing in better solutions". 'Let me be absolutely clear, HHS supports safe, effective vaccines for every American who wants them," Kennedy said in the statement. Speaking hours later Tuesday at a news conference in Anchorage, Alaska, alongside the state's two Republican US senators, Kennedy said work is under way on an alternative. He said a 'universal vaccine' that mimics 'natural immunity" is the administration's focus. 'It could be effective – we believe it's going to be effective – against not only coronaviruses, but also flu,' he said.
France 24
a day ago
- France 24
US axes mRNA vaccine contracts, casting safety doubts
The announcement, made by Health Secretary Robert F. Kennedy Jr., marks his latest effort to weave vaccine skepticism into the core of US government policy. "We reviewed the science, listened to the experts, and acted," Kennedy said in a statement. The health department's Biomedical Advanced Research and Development Authority (BARDA) is "terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu," he added. "We're shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate." The changes affect Moderna's mRNA bird flu vaccine -- a move the company itself disclosed in May -- as well as numerous other programs, including "rejection or cancellation of multiple pre-award solicitations" from pharmaceutical giants Pfizer and Sanofi. In total, the affected projects are worth "nearly $500 million," the Department of Health and Human Services (HHS) said. Certain late-stage projects were excluded from the move "to preserve prior taxpayer investment." "Let me be absolutely clear: HHS supports safe, effective vaccines for every American who wants them," Secretary Kennedy said. "That's why we're moving beyond the limitations of mRNA and investing in better solutions." Since taking office, Kennedy, who spent two decades sowing misinformation around immunization, has overseen a major overhaul of US health policy -- firing, for example, a panel of vaccine experts that advise the government and replacing them with his own appointees. In its first meeting, the new panel promptly voted to ban a longstanding vaccine preservative targeted by the anti-vaccine movement, despite its strong safety record. He has also ordered a sweeping new study on the long-debunked link between vaccines and autism. Unlike traditional vaccines, which often use weakened or inactivated forms of the target virus or bacteria, mRNA shots deliver genetic instructions into the host's cells, prompting them to produce a harmless decoy of the pathogen and train the immune system to fight the real thing. Though in development for decades, mRNA vaccines were propelled from lab benches to widespread use through President Trump's Operation Warp Speed -- a public-private partnership led by BARDA that poured billions into companies to accelerate development. The technology's pioneers, Katalin Kariko and Drew Weissman, were awarded the 2023 Nobel Prize in Medicine for their work contributing "to the unprecedented rate of vaccine development during one of the greatest threats to human health in modern times."
